01
02
03
CJC-1295
A precision-prepared compound supplied exclusively for analytical and laboratory research.
Taxes included where applicable
Research use only
Supplied exclusively for laboratory, analytical and research purposes. Not intended for human or veterinary use.
Product specification
Lyophilised presentation
Analytical research grade
Independent batch reference
Controlled preparation
Product information
Every order includes a 3ml vial of bacteriostatic water.
CJC-1295
Synthetic Growth Hormone Releasing Hormone Analogue
Precision. Purity. Research.
CJC-1295 is a synthetic peptide analogue developed from Growth Hormone Releasing Hormone (GHRH). Designed for enhanced stability during laboratory investigation, it has become one of the most widely recognised peptides within endocrine and peptide research.
Its modified molecular structure has enabled researchers to investigate receptor interactions and peptide pharmacology with exceptional consistency under controlled laboratory conditions.
Today, CJC-1295 remains an important research compound across numerous areas of peptide science.
Scientific Overview
CJC-1295 belongs to the family of synthetic GHRH analogues.
Through structural modification, researchers have been able to investigate prolonged molecular activity and receptor binding characteristics compared with naturally occurring hormone fragments.
Its extensive scientific history has established CJC-1295 as one of the cornerstone compounds in peptide research.
Certificate of Analysis (COA)
Every batch we supply is independently tested by a third-party laboratory using HPLC and mass spectrometry analysis to confirm identity and purity. Batch-specific Certificates of Analysis are being finalised and will be linked here and made available on request. For more on our testing process, see Our Process.
Specification
Storage and handling
Research notice
Supplied strictly for laboratory research and analytical purposes. Not intended for human or veterinary use.